Related Experiment Videos
[Chronic experimental bacteremia in Yucatan micropigs]
J D Peter1, V Murbach, S Bronner
1Département d'anesthésiologie, hôpital civil, hôpitaux universitaires de Strasbourg, BP 426, 67091 Strasbourg, France. Jean-Daniel.Peter@chru-strasbourg.fr
Pathologie-Biologie
|October 20, 2001
Summary
The Yucatan micropig serves as a reliable model for chronic bacteremia, closely mimicking human sepsis and organ dysfunction. This reproducible model is ideal for evaluating new antibacterial treatments.
Area of Science:
- Veterinary Medicine
- Infectious Diseases
- Animal Models
Context:
- Developing effective treatments for chronic bacteremia requires reliable animal models.
- The Yucatan micropig exhibits physiological and pharmacokinetic similarities to humans.
- Existing models may not fully replicate the complexities of human sepsis.
Purpose:
- To establish and validate the Yucatan micropig as an experimental model for chronic bacteremia.
- To assess the suitability of this model for evaluating antibacterial therapies.
Summary:
- Six adult female Yucatan micropigs were inoculated with Escherichia coli to induce chronic bacteremia.
- The model demonstrated key sepsis indicators: systemic inflammation, organ insufficiency, and positive blood cultures.
- Clinical signs included fever, anemia, thrombocytopenia, and acute tubulonephritis, mirroring human sepsis progression.
Impact:
- This validated Yucatan micropig model offers a reproducible platform for preclinical assessment of antibacterial drugs.
- It facilitates research into sepsis pathogenesis and the development of novel therapeutic strategies.
- The model's human-like characteristics enhance the translational relevance of antibacterial treatment evaluations.